Fig. 1From: First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheimer’s diseasePatient disposition. FIH First-In-Human, OLE Open label extensionBack to article page